Galectin-3 Blockade Inhibits Cardiac Inflammation and Fibrosis in Experimental Hyperaldosteronism and HypertensionNovelty and Significance

Archive ouverte

Martinez-Martinez, Ernesto | Calvier, Laurent | Fernández-Celis, Amaya | Rousseau, Elodie | Jurado-López, Raquel | Rossoni, Luciana | Jaisser, Frederic | Zannad, Faiez | Rossignol, Patrick | Cachofeiro, Victoria | López-Andrés, Natalia

Edité par CCSD ; American Heart Association -

International audience. Hypertensive cardiac remodeling is accompanied by molecular inflammation and fibrosis, 2 mechanisms that finally affect cardiac function. At cardiac level, aldosterone promotes inflammation and fibrosis, although the precise mechanisms are still unclear. Galectin-3 (Gal-3), a β-galactoside-binding lectin, is associated with inflammation and fibrosis in the cardiovascular system. We herein investigated whether Gal-3 inhibition could block aldosterone-induced cardiac inflammation and fibrosis and its potential role in cardiac damage associated with hypertension. Aldosterone-salt-treated rats presented hypertension, cardiac inflammation, and fibrosis that were prevented by the pharmacological inhibition of Gal-3 with modified citrus pectin. Cardiac inflammation and fibrosis presented in spontaneously hypertensive rats were prevented by modified citrus pectin treatment, whereas Gal-3 blockade did not modify blood pressure levels. In the absence of blood pressure modifications, Gal-3 knockout mice were resistant to aldosterone-induced cardiac inflammation. In human cardiac fibroblasts, aldosterone increased Gal-3 expression via its mineralocorticoid receptor. Gal-3 and aldosterone enhanced proinflammatory and profibrotic markers, as well as metalloproteinase activities in human cardiac fibroblasts, effects that were not observed in Gal-3-silenced cells treated with aldosterone. In experimental hyperaldosteronism, the increase in Gal-3 expression was associated with cardiac inflammation and fibrosis, alterations that were prevented by Gal-3 blockade independently of blood pressure levels. These data suggest that Gal-3 could be a new molecular mechanism linking cardiac inflammation and fibrosis in situations with high-aldosterone levels, such as hypertension.

Consulter en ligne

Suggestions

Du même auteur

Interleukin-33/ST2 system attenuates aldosterone-induced adipogenesis and inflammation

Archive ouverte | Martinez-Martinez, Ernesto | CCSD

International audience. Interleukin-33 (IL-33) but not soluble ST2 (sST2) exerts anti-inflammatory and protective effects in several tissues. Aldosterone, a proinflammatory mediator which promotes adipogenesis, is e...

Galectin-3 Participates in Cardiovascular Remodeling Associated With ObesityNovelty and Significance

Archive ouverte | Martinez-Martinez, Ernesto | CCSD

International audience. Remodeling, diastolic dysfunction, and arterial stiffness are some of the alterations through which obesity affects the cardiovascular system. Fibrosis and inflammation are important mechanis...

The Impact of Galectin-3 Inhibition on Aldosterone-Induced Cardiac and Renal Injuries

Archive ouverte | Calvier, Laurent | CCSD

International audience. OBJECTIVES:This study investigated whether galectin (Gal)-3 inhibition could block aldosterone-induced cardiac and renal fibrosis and improve cardiorenal dysfunction.BACKGROUND:Aldosterone is...

Chargement des enrichissements...